Metastatic/locally advanced
Showing 1 - 25 of >10,000
Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer Trial (Pembrolizumab, Lenvatinib)
Not yet recruiting
- Recurrent Vulvar Cancer
- +3 more
- (no location specified)
Jun 12, 2023
Solid Tumors Trial (IBR854 Cell Injection)
Not yet recruiting
- Solid Tumors
- IBR854 Cell Injection
- (no location specified)
Aug 14, 2023
Metastatic Hepatocellular Carcinoma Trial in Houston (Atezolizumab, Bevacizumab, ADI-PEG 20)
Not yet recruiting
- Metastatic Hepatocellular Carcinoma
- Atezolizumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 24, 2023
Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors Trial (RO7566802, Atezolizumab)
Not yet recruiting
- Locally Advanced Solid Tumors
- +2 more
- (no location specified)
Sep 4, 2023
Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)
Recruiting
- Differentiated Thyroid Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 9, 2023
Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)
Not yet recruiting
- Metastatic Pancreatic Cancer
- FOLFIRINOX treatment
- (no location specified)
Aug 9, 2023
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)
Recruiting
- Metastatic Breast Cancer
- +2 more
-
Ocala, FloridaOcala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023
GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY
Not yet recruiting
- Salivary Gland Cancer
- Observation
- (no location specified)
Oct 13, 2023
Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)
Recruiting
- Cancer
- +11 more
-
San Antonio, TexasSouth Texas Accelerated Research Therapeutics, LLC
Jun 21, 2023
Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets, SPH4336 Tablets Placebo)
Not yet recruiting
- Locally Advanced or Metastatic Breast Cancer
- SPH4336 Tablets
- SPH4336 Tablets Placebo
-
Guangzhou, Guangdong, ChinaAffiliated Cancer Hospital, Sun Yat-sen University
May 8, 2023
Locally Advanced or Metastatic Solid Tumors Trial in Beijing (MSC-IFNa, Nab paclitaxel, Cyclophosphamide)
Recruiting
- Locally Advanced or Metastatic Solid Tumors
- MSC-IFNα
- +3 more
-
Beijing, ChinaDepartment of Biotherapeutic, Chinese PLA General Hospital
Jan 29, 2023
NSCLC Trial (Sutetinib Maleate Capsule)
Not yet recruiting
- Non-small Cell Lung Cancer
- Sutetinib Maleate Capsule
- (no location specified)
Aug 18, 2023
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1
Not yet recruiting
- Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
- Ivosidenib 500mg
- Placebo
- (no location specified)
Nov 7, 2023
Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer
Not yet recruiting
- Locally Advanced Alveolar Soft Part Sarcoma
- +9 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 10, 2023
Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma, Determine Efficacy of Liver Transplantation After Neoadjuvant
Not yet recruiting
- Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
- Determine Efficacy of Liver Transplantation After Neoadjuvant Systemic Therapy in Patients With Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
- Liver Transplant
-
Newark, New Jersey
- +1 more
Nov 14, 2023
Locally Advanced or Metastatic Solid Tumors Trial in Guangzhou (Drug: BC3195 for Injection)
Recruiting
- Locally Advanced or Metastatic Solid Tumors
- Drug: BC3195 for Injection
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Jul 20, 2023
Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +2 more
- Enfortumab vedotin
-
Kansas City, KansasUniversity of Kansas Cancer Center
Jun 23, 2023
Quality of Life, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Cancer Trial (ARACOMPLEX®, )
Not yet recruiting
- Quality of Life
- +2 more
- ARACOMPLEX®
- placebo
- (no location specified)
Nov 28, 2022
Carcinoma Trial (Intravenous infusion anti-CEA-CAR-T cell)
Not yet recruiting
- Carcinoma
- Intravenous infusion anti-CEA-CAR-T cell
- (no location specified)
Aug 22, 2023
Solid Tumor Trial in Sydney (IBI129)
Not yet recruiting
- Solid Tumor
-
Sydney, New South Wales, AustriaSt George private Hospital
Aug 6, 2023
Locally Advanced Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial (RP3,
Not yet recruiting
- Locally Advanced Hepatocellular Carcinoma
- +2 more
- RP3
- +2 more
- (no location specified)
Feb 8, 2023
Locally Advanced or Metastatic NSCLC Trial (Utidelone Injection, Docetaxel Injection)
Not yet recruiting
- Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Utidelone Injection
- Docetaxel Injection
- (no location specified)
Dec 30, 2022